42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-945757
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => f2d13d6c-33b1-4c0f-a4d1-52e848a46c14
[Document ID] => 945757
[Document naam] => Summary table phase 3 trials COVID-19 vaccine candidates 20200930.docx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/document/VWS-WOO-08-945757
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-945757
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO
[DocumentPublicationDate] => 2 november 2020
[DocumentStatusCheckedDate] => 2026-04-29 11:40:30.306451
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 04:56:37
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 04:56:37
)
Document: VWS-WOO-08-945757
Klik om te vergroten
Document correcties
Geregistreerde datum: 20201102
Geregistreerde documentnaam: Summary table phase 3 trials COVID-19 vaccine candidates 20200930.docx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| document_SectionDownloadButton | 1 | 2025-07-10 20:25:15 |
| DocumentDownload_linkname | Download (pdf, 798.54 KB) | 2025-07-10 20:25:15 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/document/1ee694b8-ffb7-6b7c-a957-2b7b8111b989 | 2025-07-10 20:25:15 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-945757.pdf | 2025-07-10 20:25:15 |
| document_documentName | Summary table phase 3 trials COVID-19 vaccine candidates 20200930.docx | 2025-06-22 23:39:41 |
| document_documentType | Word-document | 2025-06-22 23:39:41 |
| document_documentPublicationDate | 2020-11-02 | 2025-06-22 23:39:41 |
| document_documentNumber | VWS-WOO-08-945757 | 2025-06-22 23:39:41 |
| document_SectionDownloadButton | 0 | 2025-06-22 23:39:41 |
| document_SectionHTMLDataDivs | 2 | 2025-06-22 23:39:41 |
| document_SectionAbout | 1 | 2025-06-22 23:39:41 |
| About_Datum document | 2 november 2020 | 2025-06-22 23:39:41 |
| About_Type bronbestand | Word-document, 2 pagina's | 2025-06-22 23:39:41 |
| About_Type bronbestand_paginas | 2 | 2025-06-22 23:39:41 |
| About_Download als | PDF (798.54 KB) | 2025-06-22 23:39:41 |
| About_Documentnummer | 945757 | 2025-06-22 23:39:41 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-22 23:39:41 |
| About_Gelakte gegevens | 5.1.2e Eerbiediging van de persoonlijke levenssfeer Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0045754/2022-08-01#Hoofdstuk5 | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkname_1 | 5.1.2e Eerbiediging van de persoonlijke levenssfeer | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Summary table phase 3 trials COVID-19 vaccine candidates 20200930.docx (documentnummer 1ee694b8-ffb7-6b7c-a957-2b7b8111b989) | 2025-06-22 23:39:41 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-22 23:39:41 |
| document_SectionRequest | 1 | 2025-06-22 23:39:41 |
| Request_Onderdeel van | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-22 23:39:41 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO | 2025-06-22 23:39:41 |
| Request_Onderdeel van_linkname_1 | Woo-deelbesluit aangaande Vaccinaties en Medicatie over de periode november 2020 | 2025-06-22 23:39:41 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 10 augustus 2022 een besluit genomen op verzoeken in het kader van de Wet open overheid. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en Medicatie over de periode november 2020. | 2025-06-22 23:39:41 |
| Request_Periode | November 2020 | 2025-06-22 23:39:41 |
| Request_Type besluit | Woo-besluit | 2025-06-22 23:39:41 |
| Request_Datum besluit | 10 augustus 2022 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking | 8.199 documenten, 34.478 pagina's Inventarislijst | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_documenten | 8.199 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_paginas | 34.478 | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3405320-1033219-PDO/file/download/inventory | 2025-06-22 23:39:41 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-22 23:39:41 |
Archiefversies (7 rijen)
Archiefrij 1 — 2025-09-08 18:23:14
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-945757.pdf
documentName: VWS-WOO-08-945757.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 817701
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:23:14
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:23:14
lastSeen: 2025-09-08 18:23:14
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech Janssen Sanofi* CureVac*
Vaccine AZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preSdTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline sal...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 158aec7331e02410be8d01545fa1655c0c036e276e8bc37abdd3cf946d8512e3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: folder_import_9161_57b9fd297da9edfcb7798885ce74e66a
textDigestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
Archiefrij 2 — 2025-09-04 16:59:32
fromFile: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip
documentName: VWS-WOO-08-945757.pdf
documentType: pdf
documentCompressedSize: 445799
documentSize: 817701
documentCompressRatio: 54.5185831985041
documentDateModified: 2025-05-01 20:20:46
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:59:32
lastSeen: 2025-09-04 16:59:32
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech Janssen Sanofi* CureVac*
Vaccine AZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preSdTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline sal...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 158aec7331e02410be8d01545fa1655c0c036e276e8bc37abdd3cf946d8512e3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3405320-1033219-PDO-1f026c98-54a2-616e-b0bd-65673e0af118.zip_579
textDigestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
Archiefrij 3 — 2025-09-04 16:37:56
fromFile: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip
documentName: VWS-WOO-08-945757.pdf
documentType: pdf
documentCompressedSize: 445799
documentSize: 817701
documentCompressRatio: 54.5185831985041
documentDateModified: 2025-05-27 12:38:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:37:56
lastSeen: 2025-09-04 16:37:56
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech Janssen Sanofi* CureVac*
Vaccine AZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preSdTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline sal...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 158aec7331e02410be8d01545fa1655c0c036e276e8bc37abdd3cf946d8512e3
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3405320-1033219-PDO-1f03af74-9059-6598-b46a-e1433ef450d1.zip_518
textDigestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
Archiefrij 4 — 2025-03-18 09:30:25
fromFile: 2024.075-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2024.075-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-945757.pdf
documentType: pdf
documentCompressedSize: 444692
documentSize: 817701
documentCompressRatio: 54.38320364045048
documentDateModified: 2025-01-08 16:23:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-03-18 09:30:25
lastSeen: 2025-03-18 09:30:25
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech Janssen Sanofi* CureVac*
Vaccine AZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preSdTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline sal...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 324389
textDigestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
Archiefrij 5 — 2025-02-27 09:25:04
fromFile: 2023.057-VWS-WOO-3405320-1033219-PDO.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3405320-1033219-PDO.zip
documentName: VWS-WOO-08-945757.pdf
documentType: pdf
documentCompressedSize: 444692
documentSize: 817701
documentCompressRatio: 54.38320364045048
documentDateModified: 2025-01-08 16:23:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:04
lastSeen: 2025-02-27 09:25:04
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech Janssen Sanofi* CureVac*
Vaccine AZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preSdTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline sal...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 236943
textDigestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
Archiefrij 6 — 2025-02-18 12:18:13
fromFile: VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3405320-1033219-PDO-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-945757.pdf
documentType: pdf
documentCompressedSize: 444692
documentSize: 817701
documentCompressRatio: 54.38320364045048
documentDateModified: 2025-01-08 16:23:48
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:13
lastSeen: 2025-02-18 12:18:13
text: Details phase 3trials COVID-19 vaccine candidates
AstraZeneca Moderna Pfizer/BioNtech Janssen Sanofi* CureVac*
Vaccine AZD1222 mRNA-1273 BNT162b2 RNA Ad26.COV2.S preSdTM cVnCoV
5x10" vp 100 ug 30ug 5x10% vp 5ug
PlatformViral vector mRNA mRNA Viral Vector Protein subunit|mRNA
Controlsaline saline sal...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 108478
textDigestSHA256: 5b7be99e493e5c774def01f10aaf442c4857c30f61cb9589c745a2c304a8852a
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
Archiefrij 7 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-14463f095e9ec956e456d616d78134ed0ddfad1e2cf89cd8bd19f80bc5928102.zip
documentName: VWS-WOO-08-945757-Summary_table_phase_3_trials_COVID-19_vaccine_candidates_20200930.docx.pdf
documentType: pdf
documentCompressedSize: 444692
documentSize: 817701
documentCompressRatio: 54.38320364045048
documentDateModified: 2024-08-27 10:35:18
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: leeg!
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: n/a
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: 42831
textDigestSHA256: leeg!
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-945757
(dit is ook een speeltuin)